Join now to get access to this content and more.
Become a SOAP member and have access to our benefits.
- Sample Centers of Excellence Applications
- ACOG Documents
- SOAP Policy and Procedure Manual (P&P Manual)
- SOAP Neuraxial Morphine Consensus Statement for Membership Review
- SOAP's Learning Modules
- ASA Corner
- 2019 Annual Meeting Lecture Videos
- December 2018 - SOAP Unofficial Guide to ASA Committees Webinar
- Submit a Position
- View Job Postings
- Search our Patient Safety Archive
- Ask SOAP a Question
- Our Bylaws
- Previous Meeting Archives
- Newsletter Archives
- Newsletter Clinical Articles
- Annual Meeting Publications
- CMS Guidelines
- Clinician Education
- And more…
A STOPBANG Score ≥ 3 is not associated with adverse pregnancy outcomes: A Retrospective Study
Abstract Number: T-04
Abstract Type: Original Research
Limited data suggest an association between obstructive sleep apnea (OSA) and gestational diabetes (GDM), preeclampsia, hypertension (HTN), preterm delivery, and maternal morbidity. It is established that a STOPBANG score of ≥ 3 is predictive of OSA. The primary objective of this study was to assess whether a STOPBANG score ≥ 3 is associated with adverse pregnancy outcomes.
A retrospective chart review was completed for patients who delivered at the University of Virginia between July and November of 2012 (n=397). Data systematically collected from chart reviews included age, pre-pregnancy height and weight, weight at delivery, race and ethnicity. Information about GDM, Type I DM, Type II DM, GHTN, chronic HTN, preeclampsia, preterm labor, preterm premature rupture of membranes, placental abruption, gestational age at delivery, and birth weight was also collected. The presence or absence of OSA was not confirmed with pletysmographic studies. Analyses used Fisher exact and Kruskal-Wallis tests with alpha=0.05.
Our patient population was predominantly Caucasian 69%; 25% of women were African American, 6% Asian and 20% were Hispanic. Preliminary data analysis suggests that a STOPBANG score ≥ 3 is not associated with adverse pregnancy outcomes although a borderline p value (p=0.057) was found for GDM. Patients with a STOPBANG score ≥ 3 are likely to have Type II DM (p=0.000), chronic HTN (p=0.000), and a higher pre-pregnancy body mass index (p=0.0001).
In our study an association between a STOPBANG score ≥ 3 and adverse pregnancy outcomes could not be found. This study also indicates that patients with diabetes (Type II) and hypertension are likely to have a STOPBANG score ≥ 3. Future analyses will investigate potential differences by race-ethnicity.
Burnstein, Am J Perinatol 2008; 25:561
Champagne, Eur Respir J 2009; 33:559
Chung, Brit J Anesth 2012; 108:768
Heslehurst, Obes Rev 2008; 9:635
Louis, AJOG, 2010; 202:261e1
Olivarez, AJOG, 2010; 202:552
Olivarez, Am J Perinatol 2011; 28:651